Stay updated with breaking news from Eric Landsness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tirzepatide, the active ingredient in Mounjaro and Zepbound, reduced sleep apnea symptoms in people with obesity, whether or not they used a PAP machine.
Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep apnea, according to information sent to investors of the pharmaceutical company Eli Lilly.
An implantable, FDA-approved device for obstructive sleep apnea — designed to replace a CPAP — works best for people who aren’t too overweight, a new study finds.
(CNN) — An implant for obstructive sleep apnea — a serious sleep malady in which breathing stops for 10 seconds to two minutes many times an hour each night —<a class="excerpt-read-more" href="https://whdh.com/news/cpap-replacement-works-well-for-the-overweight-not-obese-study-finds/">Read More</a>
Nerve stimulation for sleep apnea is less effective for people with higher BMIs. Popular alternative to CPAP machines may not be appropriate for all.